Vickers Philip J.
Insider CIK 1635046 · RVNC Director · AKBA Director · AVRO Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| AKBA Akebia Therapeutics, Inc. | A Award deriv | 2026-04-01 | 2026-04-03 | 214,400 | — | $0 | 214,400 | SEC↗ |
| AVRO AVROBIO, Inc. | A Award deriv | 2023-06-06 | 2023-06-08 | 17,643 | — | $0 | 17,643 | SEC↗ |
| AVRO AVROBIO, Inc. | A Award deriv | 2022-06-08 | 2022-06-10 | 17,478 | — | $0 | 17,478 | SEC↗ |
| AVRO AVROBIO, Inc. | A Award deriv | 2022-06-08 | 2022-06-10 | 17,478 | — | $0 | 17,478 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | A Award deriv | 2022-05-04 | 2022-05-06 | 11,343 | — | $0 | 11,343 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | A Award deriv | 2022-05-04 | 2022-05-13 | 10,756 | — | $0 | 10,756 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | A Award | 2022-05-04 | 2022-05-06 | 6,059 | — | $0 | 29,722 | SEC↗ |
| AVRO AVROBIO, Inc. | P Buy | 2021-07-07 | 2021-07-08 | 4,800 | $8.35 | $40.1K | 4,800 | SEC↗ |
| AVRO AVROBIO, Inc. | A Award deriv | 2021-06-10 | 2021-06-14 | 17,438 | — | $0 | 17,438 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | A Award deriv | 2021-05-05 | 2021-05-07 | 7,551 | — | $0 | 7,551 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | A Award | 2021-05-05 | 2021-05-07 | 4,013 | — | $0 | 23,663 | SEC↗ |
| AVRO AVROBIO, Inc. | A Award deriv | 2020-06-04 | 2020-06-05 | 14,000 | — | $0 | 14,000 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | A Award deriv | 2020-05-14 | 2020-05-15 | 12,000 | — | $0 | 12,000 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | A Award | 2020-05-14 | 2020-05-15 | 6,000 | — | $0 | 19,650 | SEC↗ |
| AVRO AVROBIO, Inc. | A Award deriv | 2019-06-11 | 2019-06-13 | 9,675 | — | $0 | 9,675 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | A Award deriv | 2019-05-09 | 2019-05-10 | 9,000 | — | $0 | 9,000 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | A Award | 2019-05-09 | 2019-05-10 | 4,500 | — | $0 | 13,650 | SEC↗ |
| AVRO AVROBIO, Inc. | A Award deriv | 2019-01-07 | 2019-01-09 | 18,743 | — | $0 | 18,743 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | A Award deriv | 2018-05-10 | 2018-05-11 | 6,000 | — | $0 | 6,000 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | A Award | 2018-05-10 | 2018-05-11 | 3,000 | — | $0 | 9,150 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | P Buy | 2018-03-16 | 2018-03-16 | 2,250 | $31.25 | $70.3K | 5,250 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | P Buy | 2018-03-16 | 2018-03-16 | 900 | $31.20 | $28.1K | 6,150 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | A Award deriv | 2017-05-11 | 2017-05-12 | 6,000 | — | $0 | 6,000 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | A Award | 2017-05-11 | 2017-05-12 | 3,000 | — | $0 | 3,000 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | A Award deriv | 2016-05-05 | 2016-05-09 | 8,000 | — | $0 | 8,000 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | A Award deriv | 2015-05-07 | 2015-05-15 | 8,000 | — | $0 | 8,000 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | A Award deriv | 2015-02-26 | 2015-03-02 | 18,000 | — | $0 | 18,000 | SEC↗ |